Dementia Matters 2025: Under the FTLD Umbrella: A Deep Dive into Frontotemporal Dementia
Dementia Matters is a podcast hosted by Dr. Nathaniel Chin - a geriatrician, memory clinic doctor, and medical director for the Wisconsin Alzheimer's Disease Research Center at the UW-Madison School of Medicine and Public Health. Dr. Chin interviews leading scientists and caregiving experts in the discussion of the latest news, research, and caregiver resources in Alzheimer's disease and other causes of dementia.
For more information about Dementia Matters episodes that offer continuing education credits, visit the podcast's website: https://www.adrc.wisc.edu/dementia-matters.
In this episode of Dementia Matters, listeners will learn about frontotemporal lobar degeneration. Frontotemporal lobar degeneration (FTLD) is one of the most common causes of dementia in individuals under the age of 60, yet it remains lesser known and often misunderstood. From the early symptoms to the challenges of diagnosis and treatment, FTLD presents unique hurdles for clinicians, researchers and families alike. Joining the podcast to discuss this complex disease is Dr. Brad Boeve, principal investigator of the ALLFTD study, a major national research effort aimed at identifying biomarkers and clinical tools to improve early detection of FTLD and prepare for future treatment trials. Guest: Brad Boeve, MD, neurologist, Department of Neurology and Center for Sleep Medicine, professor of neurology, Division of Behavioral Neurology, Mayo Clinic, co-director, Mayo Clinic Alzheimer’s Disease Research Center, principal investigator, ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research study. |
To claim continuing education credits using the texting function:
- Listen to the podcast episode where it is available including through the ICEP learning portal.
- See https://www.adrc.wisc.edu/dementia-matters for a list.
OR - Go to the Register tab, Click the Begin button and under the Course Progress section, click on Episode Page -> Start
- See https://www.adrc.wisc.edu/dementia-matters for a list.
- At the end of the podcast, you will receive information about texting in a code with your cell phone.
To claim continuing education credits through the ICEP online learning portal.
- Go to the Register tab, Click the Begin button and under the Course Progress section, click on Attendance Code -> Start and enter the text code given at the end of the episode.
To complete the episode evaluation:
- Go to the Register tab, Click the Begin button and under the Course Progress section, click on Episode Evaluation -> Start
*An ICEP account is required to claim credit through either method and to complete the episode evaluation form. Create an account
Intended Audience
MD/DO, RN, APRN, PA
Elements of Competence
This continuing education (CE) activity is designed to improve learner competence in the following areas:
- ABMS/ACGME Competencies: Patient care and procedural skills, Medical knowledge
- National Academy of Medicine Competencies: Provide patient-centered care
- Interprofessional Education Collaborative Competencies: Roles/responsibilities, Interprofessional communication, Teams and teamwork
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will:
- Define frontotemporal lobar degeneration (FTLD) and its causes
- Describe the symptoms of FTLD and how they may be different from the symptoms of Alzheimer’s disease
- Discuss the diagnosis process and standard of care for FTLD
- Describe the different referrals and organizations for those with FTLD
- Describe current research and major advances in FTLD research, including the ALLFTD research study
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing educational activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Bradley F. Boeve, MD, FAAN | Speaker/Author | Alector (Grant) Transposon Therapeutics (Grant) Tau Consortium (Contractor) EIP Pharma (Grant) Cognition Therapeutics (Grant) | No |
| Nathaniel Chin, MD | Committee Member, Planner, Speaker/Author | Eli Lilly and Company (Contractor) | No |
| Marcella Eveler, APNP | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Kim Hartmann, PA | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Amy Lambright Murphy | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Caoilfhinn Rauwerdink | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Grace Leonard, EdM | Planner | No relevant relationships with ineligible companies to disclose | No |
Accreditation Statement
| In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 0.75 ANCC contact hour.
American Academy of PAs (AAPA)
![]() | The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 0.75 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 8/12/2026. PAs should only claim credit commensurate with the extent of their participation. |
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .075 continuing education units (CEUs) or 0.75 hour.
Available Credit
- 0.75 AAPA Category 1 CME
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC Contact Hours
- 0.75 University of Wisconsin–Madison Continuing Education Hours
- 0.75 Approved for AMA PRA Category 1 Credit™
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to [email protected].
Accessibility
If you need anything to participate in this program, please contact [email protected]
Required Hardware/software
Computer, tablet, or other mobile device with sound (closed captioning also available).
Free, current version of Edge, Firefox, Safari, or Chrome. Some older browsers and Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.

Facebook
X
LinkedIn
Forward
